Discovery of EBI-2511: A Highly Potent and Orally Active EZH2 Inhibitor for the Treatment of Non-Hodgkin's Lymphoma
Lu, Biao
;
Shen, Xiaodong;
Zhang, Lei;
Liu, Dong;
Zhang, Caihua; et al,
ACS Medicinal Chemistry Letters,
2018,
9(2),
98-102